America Great Health
AAGH
$0.0005
$0.0004400.00%
| Weiss Ratings | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.55 | |||
| Price History | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 400.00% | |||
| 60-Day Total Return | 400.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 400.00% | |||
| 1-Year Total Return | -91.94% | |||
| 2-Year Total Return | -95.00% | |||
| 3-Year Total Return | -99.29% | |||
| 5-Year Total Return | -94.95% | |||
| 52-Week High % Change | -93.33% | |||
| 52-Week Low % Change | 400.00% | |||
| Price | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 31, 2024 | |||
| 52-Week High Price (Date) | Mar 15, 2024 | |||
| Valuation | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.57M | |||
| Enterprise Value | 12.92M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -2.50 | |||
| Enterprise Value/Revenue (TTM) | 43.83 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -16.82 | |||
| Enterprise Value/EBIT | -16.50 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 20.97B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 988 1333 | |||
| Address | 1609 W Valley Blvd Alhambra, CA 91803 | |||
| Website | www.americagreathealth.us | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -265.59% | |||
| Profit Margin | -413.98% | |||
| Management Effectiveness | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -157.14% | |||
| Return on Equity | -- | |||
| Income Statement | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 294.70K | |||
| Total Revenue (TTM) | 294.70K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 169.80K | |||
| EBITDA (TTM) | -767.90K | |||
| EBIT (TTM) | -782.70K | |||
| Net Income (TTM) | -1.22M | |||
| Net Income Avl. to Common (TTM) | -1.22M | |||
| Total Revenue Growth (Q YOY) | 28.11% | |||
| Earnings Growth (Q YOY) | -143.62% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 54.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 225.50K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -5.31M | |||
| Current Ratio (Q) | 0.063 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 323.50K | |||
| Total Current Liabilities (Q) | 3.59M | |||
| Total Debt (Q) | 2.48M | |||
| Total Liabilities (Q) | 5.64M | |||
| Total Common Equity (Q) | -5.23M | |||
| Cash Flow | AAGH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 617.30K | |||
| Net Change in Cash (TTM) | 800.00 | |||
| Levered Free Cash Flow (TTM) | 375.20K | |||
| Cash from Operations (TTM) | -615.70K | |||
